Clearside Biomedical (CLSD) Earnings Date, Estimates & Call Transcripts → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free CLSD Stock Alerts $1.25 -0.10 (-7.41%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 12EstimatedActual EPS (May. 9) -$0.17 Missed By -$0.03 Consensus EPS (May. 9) -$0.14 Read Call TranscriptListen to Call Get Clearside Biomedical Earnings AlertsEnter your email address below to receive the latest news and earnings results for CLSD and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCLSD Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CLSD Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. Clearside Biomedical Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20242($0.16)($0.12)($0.14)Q2 20242($0.15)($0.12)($0.14)Q3 20242($0.14)($0.12)($0.13)Q4 20242($0.14)($0.12)($0.13)FY 20248($0.59)($0.48)($0.54)CLSD Earnings Date and InformationClearside Biomedical last posted its quarterly earnings results on May 9th, 2024. The reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.14) by $0.03. The business had revenue of $0.23 million for the quarter, compared to analysts' expectations of $0.98 million. Clearside Biomedical has generated ($0.55) earnings per share over the last year (($0.55) diluted earnings per share). Earnings for Clearside Biomedical are expected to grow in the coming year, from ($0.56) to ($0.51) per share. Clearside Biomedical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off prior year's report dates.Read More Clearside Biomedical Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024Estimated)------- 5/9/2024Q1 2024($0.14)($0.17)($0.03)($0.17)$0.98 million$0.23 million 3/12/2024Q4 2023($0.10)($0.08)+$0.02($0.08)$3.40 million$6.35 million11/13/2023Q3 2023($0.16)($0.15)+$0.01($0.15)$0.22 million$0.86 million 8/14/2023Q2 2023($0.14)($0.15)($0.01)($0.15)$0.21 million$1.02 million5/11/2023Q1 2023($0.14)($0.15)($0.01)($0.15)--3/9/2023Q4 2022($0.13)($0.16)($0.03)($0.16)$0.16 million$0.33 million Get the Latest News and Ratings for CLSD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clearside Biomedical and its competitors with MarketBeat's FREE daily newsletter. 11/9/2022Q3 2022$0.04($0.13)($0.17)($0.13)$16.50 million$0.27 million8/9/2022Q2 2022($0.13)($0.13)-($0.13)$0.75 million$0.38 million 5/11/2022Q1 2022($0.03)($0.13)($0.10)($0.13)$9.06 million$0.35 million 3/10/2022Q4 2021$0.09$0.31+$0.22$0.31$13.16 million$25.69 million 11/10/2021Q3 2021($0.09)($0.08)+$0.01($0.08)$3.32 million$3.07 million 8/9/2021Q2 2021($0.13)($0.11)+$0.02($0.11)$0.74 million$0.78 million 5/16/2021Q1 2021($0.10)($0.13)($0.03)($0.13)$3.20 million$0.03 million Clearside Biomedical Earnings - Frequently Asked Questions When is Clearside Biomedical's earnings date? Clearside Biomedical has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, August 12th, 2024 based off last year's report dates. Learn more on CLSD's earnings history. Did Clearside Biomedical beat their earnings estimates last quarter? In the previous quarter, Clearside Biomedical (NASDAQ:CLSD) missed the analysts' consensus estimate of ($0.14) by $0.03 with a reported earnings per share (EPS) of ($0.17). Learn more on analysts' earnings estimate vs. CLSD's actual earnings. How can I listen to Clearside Biomedical's earnings conference call? The conference call for Clearside Biomedical's latest earnings report can be listened to online. Listen to Conference Call How can I read Clearside Biomedical's conference call transcript? The conference call transcript for Clearside Biomedical's latest earnings report can be read online. Read Transcript How much revenue does Clearside Biomedical generate each year? Clearside Biomedical (NASDAQ:CLSD) has a recorded annual revenue of $8.23 million. How much profit does Clearside Biomedical generate each year? Clearside Biomedical (NASDAQ:CLSD) has a recorded net income of -$32.49 million. CLSD has generated -$0.55 earnings per share over the last four quarters. What is Clearside Biomedical's EPS forecast for next year? Clearside Biomedical's earnings are expected to grow from ($0.56) per share to ($0.51) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Oramed Pharmaceuticals Earnings Results Anixa Biosciences Earnings Results BioXcel Therapeutics Earnings Results Allakos Earnings Results PMV Pharmaceuticals Earnings Results OptiNose Earnings Results Cue Biopharma Earnings Results IO Biotech Earnings Results DiaMedica Therapeutics Earnings Results Eton Pharmaceuticals Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:CLSD) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsShocking: One AI startup's revenue could surge 4,735%Manward PressCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlace[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
